{"id":62993,"date":"2026-04-23T16:02:35","date_gmt":"2026-04-23T14:02:35","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/northstar-mapping-system-now-commercially-available-in-the-united-states\/"},"modified":"2026-04-23T16:02:35","modified_gmt":"2026-04-23T14:02:35","slug":"northstar-mapping-system-now-commercially-available-in-the-united-states","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/northstar-mapping-system-now-commercially-available-in-the-united-states\/","title":{"rendered":"NorthStar Mapping System Now Commercially Available in the United States"},"content":{"rendered":"
\n

MINNEAPOLIS–(BUSINESS WIRE)–#WeareiMR<\/a>—Imricor Medical Systems, Inc.<\/b> (Company <\/b>or Imricor<\/b>) (ASX: IMR<\/b>) is pleased to announce the U.S. commercial launch of its NorthStar\u00ae<\/sup> Mapping System<\/b>.<\/p>\n

<\/a>
<\/a>
<\/a>
<\/a><\/p>\n

\nAs the first and only cardiac mapping and guidance system designed specifically to harness the power of magnetic resonance (MR) imaging to see the heart throughout a minimally-invasive interventional procedure, NorthStar brings the field of interventional MR (iMR) <\/i>to life.<\/p>\n

\nNorthStar provides physicians with an entirely new software environment through which they can visualize the heart\u2019s structure and tissue characteristics with MR imaging during an interventional procedure, unlike anything they\u2019ve used before and without requiring a single X-ray.<\/p>\n

\nFor decades, interventional procedures have relied on X-ray fluoroscopy for guidance, which offers limited soft-tissue visualization while exposing patients and clinical staff to dangerous ionizing radiation. Sensor-based interventional tools and mapping systems have been developed over the years, for use with X-ray fluoroscopy, to provide some context of the heart\u2019s geometry in an attempt to overcome what X-ray imaging cannot provide.<\/p>\n

\nThe NorthStar Mapping System fundamentally reframes what is possible by leveraging the full imaging power of MR to see the heart, to see the tissue characteristics of the heart, and to see the interventional tools within the heart, all throughout an entire procedure. NorthStar essentially transforms an MR system from being a \u201cstill camera\u201d that takes pictures for someone to look at later into a \u201cvideo camera\u201d that is viewed and manipulated in real time during a procedure, and this is technology never before delivered to the clinical market.<\/p>\n

\nIn the words of Imricor\u2019s VP of Global Sales, Greg Englehardt:
\n
<\/b>\u201cLaunching NorthStar in the U.S. marks a pivotal moment for Imricor as we enter the world\u2019s most advanced and influential healthcare market. We are bringing a truly differentiated solution to physicians. NorthStar unlocks the full potential of interventional MR, which we call ‘iMR,’ with real-time soft-tissue visualization, real-time image manipulation, and zero radiation. Our U.S. commercial team is already generating demand and building a high-quality pipeline, and we are focused on rapidly converting that momentum into early adoption across key centers.\u201d<\/p>\n

\nImricor\u2019s CEO, Steve Wedan, added:<\/b> \u201cImricor has pioneered the field of interventional MR, and we remain at the forefront of delivering a fully-realized ecosystem for cardiac interventional MR procedures. NorthStar is the clearest expression and realization of this vision. Interventional MR is here today, and at Imricor, We are iMR<\/i>.\u201d<\/p>\n

\nImricor will be showcasing the NorthStar Mapping System at the Heart Rhythm Society (HRS) Annual Scientific Sessions, beginning April 24 in Chicago, Illinois. Attendees are encouraged to visit the Imricor booth to speak with the team and see firsthand how NorthStar is redefining cardiac mapping in the iMR suite.<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia and Investor Relations Contacts:
\n
Nick Corkill
\n
VP Corporate Strategy, Imricor
\n
nick.corkill@imricor.com<\/a>
+61 450 475 633<\/p>\n

\nSimon Hinsley
\n
Executive Director, NWR
\n
simon@nwrcommunications.com.au<\/a>
+61 401 909 653<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

MINNEAPOLIS–(BUSINESS WIRE)–#WeareiMR—Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR) is pleased to announce the U.S. commercial launch of its NorthStar\u00ae Mapping System. As the first and only cardiac mapping and guidance system designed specifically to harness the power of magnetic resonance (MR) imaging to see the heart throughout a minimally-invasive interventional procedure, NorthStar brings … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62993","6":"format-standard","7":"category-industry"},"yoast_head":"\nNorthStar Mapping System Now Commercially Available in the United States - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/northstar-mapping-system-now-commercially-available-in-the-united-states\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NorthStar Mapping System Now Commercially Available in the United States - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"MINNEAPOLIS–(BUSINESS WIRE)–#WeareiMR—Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR) is pleased to announce the U.S. commercial launch of its NorthStar\u00ae Mapping System. As the first and only cardiac mapping and guidance system designed specifically to harness the power of magnetic resonance (MR) imaging to see the heart throughout a minimally-invasive interventional procedure, NorthStar brings ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/northstar-mapping-system-now-commercially-available-in-the-united-states\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-23T14:02:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260423129356\/en\/2782948\/22\/NorthStar_Upload_Shells.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/northstar-mapping-system-now-commercially-available-in-the-united-states\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/northstar-mapping-system-now-commercially-available-in-the-united-states\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"NorthStar Mapping System Now Commercially Available in the United States\",\"datePublished\":\"2026-04-23T14:02:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/northstar-mapping-system-now-commercially-available-in-the-united-states\\\/\"},\"wordCount\":488,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/northstar-mapping-system-now-commercially-available-in-the-united-states\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260423129356\\\/en\\\/2782948\\\/22\\\/NorthStar_Upload_Shells.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/northstar-mapping-system-now-commercially-available-in-the-united-states\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/northstar-mapping-system-now-commercially-available-in-the-united-states\\\/\",\"name\":\"NorthStar Mapping System Now Commercially Available in the United States - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/northstar-mapping-system-now-commercially-available-in-the-united-states\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/northstar-mapping-system-now-commercially-available-in-the-united-states\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260423129356\\\/en\\\/2782948\\\/22\\\/NorthStar_Upload_Shells.jpg\",\"datePublished\":\"2026-04-23T14:02:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/northstar-mapping-system-now-commercially-available-in-the-united-states\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/northstar-mapping-system-now-commercially-available-in-the-united-states\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/northstar-mapping-system-now-commercially-available-in-the-united-states\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260423129356\\\/en\\\/2782948\\\/22\\\/NorthStar_Upload_Shells.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260423129356\\\/en\\\/2782948\\\/22\\\/NorthStar_Upload_Shells.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/northstar-mapping-system-now-commercially-available-in-the-united-states\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NorthStar Mapping System Now Commercially Available in the United States\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NorthStar Mapping System Now Commercially Available in the United States - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/northstar-mapping-system-now-commercially-available-in-the-united-states\/","og_locale":"en_US","og_type":"article","og_title":"NorthStar Mapping System Now Commercially Available in the United States - Pharma Trend","og_description":"MINNEAPOLIS–(BUSINESS WIRE)–#WeareiMR—Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR) is pleased to announce the U.S. commercial launch of its NorthStar\u00ae Mapping System. As the first and only cardiac mapping and guidance system designed specifically to harness the power of magnetic resonance (MR) imaging to see the heart throughout a minimally-invasive interventional procedure, NorthStar brings ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/northstar-mapping-system-now-commercially-available-in-the-united-states\/","og_site_name":"Pharma Trend","article_published_time":"2026-04-23T14:02:35+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260423129356\/en\/2782948\/22\/NorthStar_Upload_Shells.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/northstar-mapping-system-now-commercially-available-in-the-united-states\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/northstar-mapping-system-now-commercially-available-in-the-united-states\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"NorthStar Mapping System Now Commercially Available in the United States","datePublished":"2026-04-23T14:02:35+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/northstar-mapping-system-now-commercially-available-in-the-united-states\/"},"wordCount":488,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/northstar-mapping-system-now-commercially-available-in-the-united-states\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260423129356\/en\/2782948\/22\/NorthStar_Upload_Shells.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/northstar-mapping-system-now-commercially-available-in-the-united-states\/","url":"https:\/\/pharma-trend.com\/en\/northstar-mapping-system-now-commercially-available-in-the-united-states\/","name":"NorthStar Mapping System Now Commercially Available in the United States - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/northstar-mapping-system-now-commercially-available-in-the-united-states\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/northstar-mapping-system-now-commercially-available-in-the-united-states\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260423129356\/en\/2782948\/22\/NorthStar_Upload_Shells.jpg","datePublished":"2026-04-23T14:02:35+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/northstar-mapping-system-now-commercially-available-in-the-united-states\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/northstar-mapping-system-now-commercially-available-in-the-united-states\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/northstar-mapping-system-now-commercially-available-in-the-united-states\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260423129356\/en\/2782948\/22\/NorthStar_Upload_Shells.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260423129356\/en\/2782948\/22\/NorthStar_Upload_Shells.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/northstar-mapping-system-now-commercially-available-in-the-united-states\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"NorthStar Mapping System Now Commercially Available in the United States"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62993","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62993"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62993\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62993"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62993"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62993"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}